Phase 1 study

Recruiting Phase 1

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 1
Sponsor EtiraRx Australia Pty Ltd
Registry number NCT06533332
Started 14 October 2024 Today 16 October 2026 Estimated completion 30 December 2026

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Macquarie University Health Ryde NSW Recruiting
The Kinghorn Cancer Center Sydney NSW Recruiting
Westmead Hospital Westmead NSW Recruiting
Cancer Research SA Adelaide SA Recruiting
Icon Cancer Centre Adelaide Adelaide SA Recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years and over
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 36

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

* Patients must be at least 18 years of age at the time of signing the informed consent.

* Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1.

* Patients must have histologically or cytologically confirmed solid tumor, primarily including but not limited to breast, ovarian, pancreatic, endometrial and hepatocellular carcinoma, that is advanced unresectable and/or metastatic disease for whom standard therapies do not exist or are no longer effective

* Patients must have measurable disease as per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1.

* Adequate baseline organ function and hematologic function

* Life expectancy \>3 months

Exclusion Criteria:

* Systemic anti cancer therapy within 4 weeks of first dose of study drug

* Major surgery (as defined by the Investigator) within 4 weeks of first dose of study drug.

* Uncontrolled intercurrent illnesses

* Known history of LIPA deficiency, such as Wolman disease or Cholesterol ester storage disease.

Dates on the record

Started 14 October 2024
Estimated completion 30 December 2026
Registry last updated 29 May 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 29 May 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.